Furthermore, patients underwent curative radical prostatectomy and pelvic lymphadenectomy in only 67/100 cases (67%) therefore the use of [68Ga]Ga-PSMA-11 PET/CT in combination with PSA levels could be proposed as gold standard for primary staging in prostate cancer. The gene discussed is FOLH1; the disease is prostate cancer.